De Novo Cleared For Sonablate Device After Panel Rejects PMA
This article was originally published in The Gray Sheet
The ultrasound unit for the ablation of prostate tissue was cleared via the de novo process. Last year, an FDA advisory panel recommended against approving a PMA on the device due to what the experts said were insufficient clinical trial results.
Register for our free email digests: